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Introduction
•  VAP is the 2nd most common nosocomial infection. 
   15% of all hospital acquired infections
•  Incidence:  
   9% to 70% occurrence in patients on ventilators
•  Increased ICU stay by several days.
•  Increased avg. hospital stay 1 to 3 weeks.
•  Mortality: 
   13% to 55%
•  Added costs of $40,000–$50,000 per stay.
Centers for Disease Control and Prevention, 2003. Rumbak, M. J. (2002).  Strategies for prevention and treatment 
Journal of Respiratory Disease, 21 (5), p. 321; 
Changing Views of Ventilator 
Associated Pneumonia 
•  No longer just an “unfortunate” occurrence.
•  Viewed as medical error:
   Institute of Medicine
   Leapfrog Group
•  TJC – hospitals required to show VAP prevention/ 
reduction measures:
   Act 52 requires family notifi cation!













































Incidence of pneumonia increased 
steadily with the accumulation of 
pepsin-positive trachael secretions 
(PPTS[%], proxy for aspiration event). 
The mean number of pepsin-positive 
trachael secretions per patient on 
day 1 was 1.62; at the end of day 2 
the total accumulated number per 
patient was 3.21; and at the end of 




















*Hi-Low Evac Tube 
Implementation
Conclusion 
•  VAP rate reduced from 78 from 64 from 2007-2008.
•  Potentially 6.44 lives saved.
•  Potentially $560,000 saved.
•  VAP rate now 18!
•  VAP rate below national standard!
•  STILL ROOM for IMPROVEMENT!
Methods:Steps to Reduce VAPS
•  Implementation of Ventilator Bundles.
•  Diligent ventilator management.
•  Utilization of non-invasive ventilation.
•  Early tracheostomy?
•  Hi/Lo Evac endotracheal tube.







Advanced Cuff Technology 
Seal Guard
•  Unique, tapered-shape cuff made from  stronger, 
ultra-thin polyurethane
   Reduces leakage past the cuff 
by at least 95% compared to 
conventional, high- volume, 
low-pressure cuffs*.
   Improved sealing performance 
occurs at a 20% lower  intra-
cuff pressure*.
